fibrinolyt activ platelet function hypertens possibl influenc calcium antagon patient mild hypertens day placebo age- gender-match group healthi volunt platelet aggreg fibrinolyt activ hypertens calcium antagonist isradipin month blood determin platelet aggreg fibrinolyt activ week month treatment platelet aggreg hypertens control lower adenosin diphosph adp valu irrevers aggreg tissue-plasminogen activ t-pa activ hypertens control therapi platelet aggreg t-pa activ present data fibrinolyt activ platelet aggreg mild hypertens blood pressure-low effect isradipin thromboembol diseas platelet function fibrinolyt activ 